Avexitide

Overview

Avexitide is under investigation in clinical trial NCT02996812 (Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia).

Background

Avexitide is under investigation in clinical trial NCT02996812 (Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans	2025/05/15	NCT06972407	Phase 2	Not yet recruiting	Mayo Clinic
The Role of Islet GLP-1 in the Pathogenesis of Prediabetes	2025/05/13	NCT06967558	Phase 2	Not yet recruiting	Mayo Clinic
Avexitide for Treatment of Post-Bariatric Hypoglycemia	2024/12/24	NCT06747468	Phase 3	Recruiting	Amylyx Pharmaceuticals Inc.
Avexitide Safety and Efficacy to Treat Acquired Hyperinsulinemic Hypoglycemia	2020/12/03	NCT04652479	Phase 2	Completed	Dr. Tracey McLaughlin, MD
Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric Hypoglycemia	2017/12/14	NCT03373435	Phase 2	Completed	Eiger BioPharmaceuticals
The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D	2017/08/11	NCT03246451	Not Applicable	Completed	University Hospital, Gentofte, Copenhagen
Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines	2017/08/07	NCT03241303	Not Applicable	Completed	University Hospital, Gentofte, Copenhagen
Cardiovascular Effects of GLP-1 Receptor Activation	2017/04/05	NCT03101930	Phase 4	Completed	Vanderbilt University Medical Center
Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia	2016/12/19	NCT02996812	Phase 1	Completed	Tracey McLaughlin
Regulation of Insulin Secretion by the GLP-1 Receptor	2016/07/26	NCT02844907	Phase 4	Terminated	VA Office of Research and Development

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

AI-Powered Research

Premium Access